Biotech General Inception acquires Enable Medicine and announces strategic partnership to accelerate drug discovery with AI-led generative biological search December 12, 2024
Biotech Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer December 12, 2024
Biotech Kanazawa University research: How Cells Repair DNA’s Protective Barrier: A pathway to address a rare genetic disorder characterized by rapid aging in children December 11, 2024
Biotech Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer December 11, 2024
Biotech Resolution Therapeutics Announces Presentation at Keystone Symposia on Fibrosis December 10, 2024
Biotech Kling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution Platform December 10, 2024
Biotech Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH December 9, 2024
Biotech Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting December 9, 2024
Biotech BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) December 8, 2024